Clinical Trials on Gaucher Disease, Type 2 in Belgium

Total 1843 results

Novo Nordisk A/S

Completed

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

United Kingdom, France, Netherlands, Belgium, Ireland
Nina Hermans
University Hospital, Antwerp

Recruiting

Extracts of Amla, Walnut Leaf, Red Yeast Rice and Olive in Cardiovascular Prevention (AmWaRO)

Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

Hiv | Human Papilloma Virus | Organ Transplants

Belgium
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
Jules Bordet Institute

Completed

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs (LUMEN)

Gastroenteropancreatic Neuroendocrine Tumors

Belgium
Hasselt University
Jessa Hospital

Completed

Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.

Diabetes Mellitus, Type 1

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Completed

Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes (CRISTAL)

Type1 Diabetes

Belgium, Netherlands
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Type 2 Diabetes Mellitus | Diabetic Nephropathy

Poland, United Kingdom, Germany, Belgium, Hungary, Czechia
Universitair Ziekenhuis Brussel

Active, not recruiting

Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC) (myDCTV)

Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Centre Georges Francois Leclerc

Completed

Simultaneous Integrated Boost (SIB)- IMRT

Carcinoma, Squamous Cell

Belgium
Hasselt University
Jessa Hospital

Completed

Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity (GIIADMT1)

Diabetes Mellitus, Type 1

Belgium
Cliniques universitaires Saint-Luc- Université...
Immutep S.A.S.

Terminated

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Institut Pasteur

Unknown

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients (THERAVAC)

Melanoma

Belgium
Bayer

Completed

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD)

Diabetic Kidney Disease

Belgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
University Hospital, Ghent

Terminated

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) (TRACE)

Hepatocellular Carcinoma

Belgium
CDx Diagnostics

Completed

Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma

Barrett Esophagus | Esophageal Adenocarcinoma | Esophageal Dysplasia

Belgium
University Hospital, Ghent
Jessa Hospital; University Hospital, Antwerp; AZ Sint-Jan AV; AZ Delta; General Hospital... and other collaborators

Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs (BLOOD)

Melanoma | Cancer

Belgium
CureVac
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus

Belgium, Germany
prof. dr. Ilse Degreef

Active, not recruiting

Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device (Vivosorb)

Dupuytren Contracture | Dupuytren Disease of Palm and Finger

Belgium
Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes (SimpleMix™)

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom, Poland, Spain, India, Argentina, China
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Metastatic Melanoma

Belgium
Universitair Ziekenhuis Brussel

Completed

Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients

Malignant Melanoma

Belgium
Stichting Hemato-Oncologie voor Volwassenen Nederland

Active, not recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL (HO152)

Lymphoma, B-Cell | Non Hodgkin Lymphoma | High-grade B-cell Lymphoma | MYC Translocation | BCL-2 Translocation

Netherlands, Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Malignant Melanoma

Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Malignant Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Metastatic Melanoma

Belgium
University Ghent
Belgian Federation Against Cancer

Completed

Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis (MMT)

Peritoneal Carcinomatosis

Belgium
Erasme University Hospital
AZ Sint-Jan AV; Cliniques universitaires Saint-Luc- Université Catholique de... and other collaborators

Completed

PAtient-PHYsician Relationship Assessment (PAPHYRA)

Hepatocellular Carcinoma

Belgium
BTG International Inc.

Terminated

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Belgium
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Diabetes Mellitus, Type 2

Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
Universitaire Ziekenhuizen KU Leuven

Recruiting

Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology (MUSA1)

Myoma;Uterus | Sarcoma Uterus

Belgium
Hasselt University
Ziekenhuis Oost-Limburg

Unknown

Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment (COBOX)

Colorectal Peritoneal Carcinomatosis

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency (GLYCO-1B)

Glucose 6 Phosphatase Deficiency | Glycogen Storage Disease Type I

Belgium
University Hospital, Ghent

Completed

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Colorectal Neoplasms

Belgium
Catherine Vandepitte, M.D.
Pacira Pharmaceuticals, Inc

Completed

Liposome Bupivacaine for WRIST Blocks

Dupuytren's Contracture of the Hand (Viking's Disease)

Belgium
Novartis Pharmaceuticals

Terminated

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Diabetes Mellitus and Heart Failure

United States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
University Ghent
Research Foundation Flanders; Special Research Fund, Belgium

Completed

PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?

High-grade Glioma of the Brain

Belgium
European Hepatocellular Cancer Liver Transplant...

Completed

A Worldwide Score for Hepatocellular Cancer and Liver Transplantation (TRAIN-SCORE)

Recurrence | Liver Cancer | Dropout, Patient

Belgium
Asylia Diagnostics BV

Recruiting

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Melanoma | Lung Cancer

Belgium
Universitair Ziekenhuis Brussel
University Hospital, Ghent

Recruiting

Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (COMBI-R2)

Melanoma

Belgium
University Hospital, Ghent
Universitaire Ziekenhuizen KU Leuven; University Hospital, Antwerp; Cliniques...

Recruiting

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma (GLITCA)

Liver Transplantation | Hepatocellular Carcinoma | Prognostic Biomarker | Diagnostic Biomarker

Belgium
University Hospital, Antwerp
University of Padova; Campus Bio-Medico University; Université Montpellier; Indigo...

Completed

cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 Diabetes

Diabetes Mellitus, Type 1

Belgium
Universitaire Ziekenhuizen KU Leuven
Onze Lieve Vrouwziekenhuis Aalst

Completed

Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites (OUT OF SIGHT)

Diabetes Mellitus, Type 1

Belgium
AZ-VUB
Universitaire Ziekenhuizen KU Leuven; Vrije Universiteit Brussel; Universiteit... and other collaborators

Completed

Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes

Diabetes Mellitus, Type 1

Belgium
Boehringer Ingelheim

Completed

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Diabetes Mellitus, Type 2

Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
Universitaire Ziekenhuizen KU Leuven

Unknown

Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

Neurofibromatosis Type 1

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Genomic Analysis of Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Belgium
Jules Bordet Institute

Withdrawn

Randomized Phase III of PRRT Versus Interferon (CASTOR)

Gastro-intestinal Neuroendocrine Tumors

Belgium
Bart Neyns

Completed

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Melanoma

Belgium
Universitair Ziekenhuis Brussel

Not yet recruiting

A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma (NEO-GLITIPNI)

Recurrent Glioblastoma

Belgium

Clinical Trials on Gaucher Disease, Type 2 in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations